Literature DB >> 28689810

LincRNA-p21 knockdown enhances radiosensitivity of hypoxic tumor cells by reducing autophagy through HIF-1/Akt/mTOR/P70S6K pathway.

Yueming Shen1, Yingying Liu1, Ting Sun2, Wei Yang3.   

Abstract

Hypoxic conditions are common in solid tumors and have a significant effect on tumor progression, therapeutic and prognosis. Long noncoding RNAs (lncRNAs) are longer than 200 nucleotides and cannot be translated into proteins, which play important roles in some diseases including cancer. Although previous analysis have showed that long intergenic non-coding RNA (lincRNA)-p21 is hypoxia-responsive and functions as a new regulator of cell cycle, apoptosis and warburg effect in cervical cancer, its biological roles in hypoxic hepatoma and glioma are unknown. In this work, we found that X-ray irradiation or hypoxia treatment elevated lincRNA-p21 expression in SMMC7721 hepatoma and U251MG glioma cells. Knockdown of lincRNA-p21 induced G2/M phase arrest, promoted apoptosis, decreased cell proliferation and motility, and reduced autophagy through HIF-1/Akt/mTOR/P70S6K pathway in hypoxic tumor cells. Our results delineated a novel mechanism of lincRNA-p21 in enhancing hypoxic tumor cell radiosensitivity, which might provide valuable targets for radiation therapy for solid tumors, such as hepatoma and glioma.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Hypoxia; LincRNA-p21; Radiosensitivity

Mesh:

Substances:

Year:  2017        PMID: 28689810     DOI: 10.1016/j.yexcr.2017.06.016

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  17 in total

Review 1.  The role of lincRNA-p21 in regulating the biology of cancer cells.

Authors:  Yan Huang; Qian Yi; Jianguo Feng; Wei Xie; Wei Sun; Weichao Sun
Journal:  Hum Cell       Date:  2022-08-15       Impact factor: 4.374

Review 2.  Introduction of long non-coding RNAs to regulate autophagy-associated therapy resistance in cancer.

Authors:  Yanyan Wang; Zhaoping Liu; Zhenru Xu; Wenjun Shao; Dingyu Hu; Huiying Zhong; Ji Zhang
Journal:  Mol Biol Rep       Date:  2022-07-09       Impact factor: 2.316

Review 3.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

4.  Modulation of mTOR signaling by radiation and rapamycin treatment in canine mast cell cancer cells.

Authors:  Morla Phan; Changseok Kim; Anthony Mutsaers; Valerie Poirier; Brenda Coomber
Journal:  Can J Vet Res       Date:  2022-01       Impact factor: 0.897

5.  Inhibition of long non-coding RNA HOTAIR enhances radiosensitivity via regulating autophagy in pancreatic cancer.

Authors:  Chunli Wu; Liang Yang; Xun Qi; Taifang Wang; Meng Li; Ke Xu
Journal:  Cancer Manag Res       Date:  2018-11-02       Impact factor: 3.989

Review 6.  Regulatory effects of lncRNAs and miRNAs on autophagy in malignant tumorigenesis.

Authors:  Qingqing Yin; Wei Feng; Xianjuan Shen; Shaoqing Ju
Journal:  Biosci Rep       Date:  2018-10-22       Impact factor: 3.840

7.  Long noncoding RNA UFC1 is activated by E2F1 and exerts oncogenic properties by functioning as a ceRNA of FOXP3.

Authors:  Jie Xi; Jing Feng; Saitian Zeng; Ping Huang
Journal:  Cancer Med       Date:  2018-05-23       Impact factor: 4.452

8.  LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression.

Authors:  Qun Zhou; Hengji Zhan; Fan Lin; Yuhan Liu; Kang Yang; Qunjun Gao; Mengting Ding; Yuchen Liu; Weiren Huang; Zhiming Cai
Journal:  Biosci Rep       Date:  2019-04-12       Impact factor: 3.840

Review 9.  Autophagy-Modulating Long Non-coding RNAs (LncRNAs) and Their Molecular Events in Cancer.

Authors:  Md Zahirul Islam Khan; Shing Yau Tam; Helen Ka Wai Law
Journal:  Front Genet       Date:  2019-01-14       Impact factor: 4.599

Review 10.  mRNA-to-protein translation in hypoxia.

Authors:  Nancy T Chee; Ines Lohse; Shaun P Brothers
Journal:  Mol Cancer       Date:  2019-03-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.